Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Stéphanie Saada"'
1
Akademický článek
Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients.
Autor: Maura Campitelli, Emmanuelle Jeannot, Martine Peter, Emmanuelle Lappartient, Stéphanie Saada, Anne de la Rochefordière, Virginie Fourchotte, Séverine Alran, Peter Petrow, Paul Cottu, Jean-Yves Pierga, Olivier Lantz, Jérôme Couturier, Xavier Sastre-Garau
Publikováno v: PLoS ONE, Vol 7, Iss 8, p e43393 (2012)
INTRODUCTION: In most cases of cervical cancers, HPV DNA is integrated into the genome of carcinoma cells. This mutational insertion constitutes a highly specific molecular marker of tumor DNA for every patient. Circulating tumor DNA (ctDNA) is an em
Externí odkaz: https://doaj.org/article/75d513165e2147a0a74f89e9f66801f4
Zobrazit plný text záznamu
4
Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma
Autor: Marie-Ange Calméjane, Emmanuelle Lappartient, Dominique Bellet, Xavier Sastre-Garau, Stéphanie Saada, Evelyne Ruff, Maura Campitelli, Allyson Holmes, Emmanuelle Jeannot, Véronique Becette
Publikováno v: Journal of Pathology: Clinical Research
Journal of Pathology: Clinical Research, 2016, 2 (4), pp.201-209. ⟨10.1002/cjp2.47⟩
Journal of Pathology: Clinical Research, Wiley Open Access, 2016, 2 (4), pp.201-209. ⟨10.1002/cjp2.47⟩
The Journal of Pathology: Clinical Research
International audience; Specific human papillomavirus genotypes are associated with most ano-genital carcinomas and a large subset of oro-pharyngeal carcinomas. Human papillomavirus DNA is thus a tumour marker that can be detected in the blood of pat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc64639784b1742f636486827e40e31
https://cnrs.hal.science/hal-03292040
Zobrazit plný text záznamu
5
Adaptation of methotrexate determination in serum with Unicel DxC600®
Autor: Sandra Berrafato, Xavier Sastre, François Lokiec, Brigitte Olichet, Frédéric Troalen, Thierry Bronzini, Keyvan Rezai, Stéphanie Saada
Publikováno v: Annales de biologie clinique. 70:277-286
Le traitement par methotrexate haute dose necessite un suivi pharmacologique afin d’adapter les traitements de sauvegarde pour limiter les effets secondaires. L’etude realisee a ete menee afin de valider l’adaptation du reactif EMIT sur l’Uni
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c53b04800e613f3912e26e2455b1d2e
https://doi.org/10.1684/abc.2012.0708
Zobrazit plný text záznamu
6
Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma
Autor: Marc-Henri Stern, David Gentien, Fariba Nemati, Aurélie Thuleau, Olivier Lantz, Pascale Mariani, Franck Assayag, Jordan Madic, Stéphanie Saada, Vincent Servois, Didier Decaudin, Maud Milder, Bénédicte Trouiller, François-Clément Bidard, Sophie Piperno-Neumann, Aurore Rampanou, Laurence Desjardins
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 18(14)
Purpose: To develop a molecular tool to detect circulating tumor–derived DNA (ctDNA) in the plasma from patients with uveal melanoma as a marker of tumor burden and monitor treatment efficacy. Experimental Design: A real-time PCR was developed on t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb4e87fc2251539a7ceced8f1b7898c9
https://pubmed.ncbi.nlm.nih.gov/22645051
Zobrazit plný text záznamu
7
Human Papillomavirus Mutational Insertion: Specific Marker of Circulating Tumor DNA in Cervical Cancer Patients
Autor: Martine Peter, Maura Campitelli, Jérôme Couturier, Emmanuelle Jeannot, Emmanuelle Lappartient, Paul Cottu, Xavier Sastre-Garau, Jean-Yves Pierga, Anne de la Rochefordière, Virginie Fourchotte, Olivier Lantz, Séverine Alran, Peter Petrow, Stéphanie Saada
Publikováno v: PLoS ONE, Vol 7, Iss 8, p e43393 (2012)
PLoS ONE
INTRODUCTION: In most cases of cervical cancers, HPV DNA is integrated into the genome of carcinoma cells. This mutational insertion constitutes a highly specific molecular marker of tumor DNA for every patient. Circulating tumor DNA (ctDNA) is an em
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::753a8f833dde5dc812ad73e1bf9c6663
https://doi.org/10.1371/journal.pone.0043393
Zobrazit plný text záznamu
8
Abstract C48: Detection of GNAQ/GNA11 mutations in circulating cell-free DNA as a biomarker of uveal melanoma
Autor: Maud Milder, Stéphanie Saada, Jordan Madic, Fariba Nemati, Marc-Henri Stern, Franck Assayag, Sophie Piperno-Neumann, David Gentien, Laurence Desjardins, Olivier Lantz, Benedicte Trouillet, Didier Decaudin
Publikováno v: Molecular Cancer Therapeutics. 10:C48-C48
Background: Circulating tumor-derived DNA (ctDNA) can be detected in the plasma of cancer patients. Recently, ctDNA was proposed as a biomarker to follow tumor burden and monitor treatment efficacy (1). However, ctDNA represents a tiny fraction of th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0123e0675ee1d7df241c3796eedc2394
https://doi.org/10.1158/1535-7163.targ-11-c48
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje